Sana Biotechnology

Developer of engineered cell therapies for treating various human diseases

placeSeattle, Washington, United States calendar_todayFounded 2018 groups328 employees language sana.com

Registered entities

Innovation

79 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace accelerating. Cited 14,222 times.

YearFilings
20219
202220
202346
202449
202540
202613

Social engagement

Social engagement: 51.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include F-Prime Capital, Arch Venture Partners, Flagship Pioneering, CPP Investments; 3 have since exited.

Investor typeCountShare
Venture capital1579%
Other / undisclosed421%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

5 Jan 2026 · Director, External Quality Assurance · Cambridge

3 Dec 2025 · Scientist / Principal Research Associate, Beta Islet · Cambridge

5 Oct 2025 · Exec. Dr. Clinical OperationsNewCambridge, MA; South San Francisco, CA · Cambridge

13 Aug 2025 · Head of Pre-clinical Pharmacology and ToxicologyCambridge, MA · Cambridge

12 Aug 2025 · Senior Scientist, Beta IsletCambridge, MA · Cambridge

Based on job postings tracked across public sources.

Recent activity

8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
2 Jun 2026
Event
Jefferies Global Healthcare Conference
11 May 2026
Event
Bank of America Health Care Conference 2026
Coming soon